Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T Cells.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Shingo OkunoHitoshi Kiyoi

Abstract

Despite the remarkable initial efficacy of CD19 chimeric Ag receptor T (CAR-T) cell therapy, a high incidence of relapse has been observed. To further increase treatment efficacy and reduce the rate of escape of Ag-negative cells, we need to develop CAR-T cells that target other Ags. Given its restricted expression pattern, CD37 was considered a preferred novel target for immunotherapy in hematopoietic malignancies. Therefore, we designed a CD37-targeting CAR-T (CD37CAR-T) using the single-chain variable fragment of a humanized anti-CD37 Ab, transmembrane and intracellular domains of CD28, and CD3ζ signaling domains. High levels of CD37 expression were confirmed in B cells from human peripheral blood and bone marrow B cell precursors at late developmental stages; by contrast, more limited expression of CD37 was observed in early precursor B cells. Furthermore, we found that human CD37CAR-T cells with longer spacer lengths exhibited high gene transduction efficacy but reduced capacity to proliferate; this may be due to overactivation and fratricide. Spacer length optimization resulted in a modest transduction efficiency together with robust capacity to proliferate. CD37CAR-T cells with optimized spacer length efficiently targete...Continue Reading

References

Feb 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Annemiek B van SprielMark D Wright
Dec 18, 2004·Methods in Cell Biology·Brent Wood
Dec 18, 2008·European Journal of Immunology·Kuo-Ching ShengMark D Wright
Feb 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Carmine CarpenitoCarl H June
Mar 14, 2009·PLoS Pathogens·Annemiek B van SprielCarl G Figdor
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
May 26, 2012·Cancer Cell·Rosa LapalombellaJohn C Byrd
Apr 27, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael HudecekStanley R Riddell
Nov 20, 2013·Immunologic Research·Louis GonzalezEckhard R Podack
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James N KochenderferSteven A Rosenberg
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Dec 19, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keisuke WatanabeMakoto Murata
Apr 9, 2015·Frontiers in Physiology·Kyle A BeckwithNatarajan Muthusamy
May 9, 2015·Histochemistry and Cell Biology·Charlotte M de WindeAnnemiek B van Spriel
Jan 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Frederick L LockeWilliam Y Go
Oct 5, 2017·The New England Journal of Medicine·Robert MarcusWolfgang Hiddemann
Nov 29, 2017·Cancer Immunology Research·Sarah A RichmanMichael C Milone
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shivani Srivastava, Stanley R Riddell
Feb 1, 2018·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Feb 1, 2018·The New England Journal of Medicine·Jae H ParkMichel Sadelain
Mar 6, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wei XiongDongfang Liu
Nov 6, 2018·Molecular Therapy : the Journal of the American Society of Gene Therapy·Diogo Gomes-SilvaMaksim Mamonkin
Dec 7, 2018·The New England Journal of Medicine·Stephen J SchusterUNKNOWN JULIET Investigators
Apr 14, 2019·Blood Advances·Hakan KöksalSébastien Wälchli
Apr 24, 2019·Nature Medicine·Zhitao YingSi-Yi Chen
May 22, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Radhakrishnan RamchandrenStephen M Ansell

❮ Previous
Next ❯

Citations

Oct 6, 2021·Cancer Science·Shouhei MiyagiHiroshi Kimura

❮ Previous
Next ❯

Related Concepts

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

Zhongguo shi yan xue ye xue za zhi
Wei WangYi-Gai Ma
Journal of Biological Regulators and Homeostatic Agents
G Moldenhauer
The Journal of Immunology : Official Journal of the American Association of Immunologists
Annemiek B van SprielMark D Wright
International Journal of Molecular Sciences
Malgorzata BobrowiczMagdalena Winiarska
© 2021 Meta ULC. All rights reserved